|
||||||||||
|
||||||||||
Fabio Pammolli |
||||||||||
PresentationFabio Pammolli (1965) E-mail: f.pammolli@imtlucca.it ; direttore@imtlucca.it ; pammolli@gmail.com
Full Professor of Economics and Management, IMT Institute For Advanced Studies, Lucca, Italy (www.imtlucca.it). Director, IMT Institute For Advanced Studies, Lucca, Italy (www.imtlucca.it). IMT is an Institute for Advanced Studies and a Graduate School, founded in 2005, which aims to push the frontiers of knowledge and to contribute to the formation of international professional elites for business and institutions. Director, CERM Foundation, Rome, Italy (www.cermlab.it). Coordinator, Ph.D. Program in Economics, Markets, Institutions, IMT Institute for Advanced Studies, Lucca, Italy (http://www.imtlucca.it/phd_programs/economics_markets_institutions/index.php) . Research Fellow, Boston University, Dept. of Physics, Boston (http://polymer.bu.edu/staff.html). Member, Pension Expenditure Assessment Board, Ministry of Labour and Social Policies and Ministry of Economy and Finance, 2011 - present. Degree in Economics, University of Pisa. Graduate Studies, The Sant'Anna School of Advanced Studies (1989-1991); Visiting Research Fellow, Northeastern University (1990), Boston, Ma.; Visiting Scholar, Massachusetts Institute of Technology (1991), Boston, Ma.; Visiting Research Fellow, SCANCOR, Stanford University (2001), Stanford, Ca. Pammolli's research deals with multiscale analysis of economic systems; economics of innovation, industry structure, and dynamics; the political economy of health and pensions. Google Scholar h index = 23; Scopus h index = 13. He has published in journals such as: Nature Reviews, The Proceedings of the National Academy of Sciences (cover article, dec 27, 2005, vol. 102, n. 52), The Journal of the European Economics Association, The International Journal of Industrial Organization, Management Science, European Management Review, Physical Review E, Physica-A, Revue d'Economie Industrielle, Research Policy, Small Business Economics, Health Affairs, R&D Management, E. Journal of Health Economics, Europhysics Letters, Economics Letters, The European Physical Journal B. Author, Global Competitiveness in Pharmaceuticals: A European Perspective, DG Enterprise, European Commission; Innovation and Competitiveness in European Biotechnology, DG Enterprise, European Commission; Medical Devices Competitiveness and Impact on Public Health Expenditure, DG Enterprise, European Commission; Pharmaceuticals, in EU Competitiveness Report European Commission, Brussels. Member, Commission on Intellectual Property Rights, Innovation and Public Health (CIPIH), World Health Organization, and contributed to the report on Public Health, Innovation and Intellectual Property Rights, CIPIH, World Health Organization, 2006. He has contributed to the "Libro bianco sul futuro del modello sociale", Ministry of Welfare, Rome. Member, Scientific Committee, Smith Kline Foundation, 2011 - present. Publications and position papers on political economy and structural reforms in Italy are available at: www.cermlab.it. Director EPRIS project, funded by the Merck Foundation, 2001-2008. Member, Scientific Committee, National Institutes of Health, Rome Italy, 2001 - 2006. He serves as an advisor of private multinational companies and foundations. He has participated in research projects sponsored by national and international agencies and foundations. He has presented the findings of his research in seminars, conferences and given invited lectures at, among the others: National Bureau of Economic Research, London School of Economics, Massachusetts Institute of Technology, Stanford University, Columbia University, Berkeley University, the OECD, European Econometrics Society, Ecole de Mines, Ecole Polytechnique, The Johns Hopkins University, the AAAS, the Council of Foreign Relations, The Royal Institute of International Affairs.
- F. Pammolli, 2012, "Persistence and Uncertainty in The Academic Career", (with A. M. Petersen, M. Riccaboni, H. E. Stanley), Proceedings of the National Academy of Sciences, 109(14), 5135-5548 - F. Pammolli, 2012, "The Evolution of Complex Networks: A New Framework", (with G. Caldarelli, A. Chessa, I. Crimaldi), technical report - F. Pammolli, 2012, "Learning from Failures or Failing to Learn? Lessons from Pharmaceutical R&D", (with L. Magazzini, M. Riccaboni), European Management Review, 9(1), 45-58 - F. Pammolli, 2012, "The Value of Failures in Pharmaceuticals R&D", (with J. Chiou, L. Magazzini, M. Riccaboni), working paper (EIC Working Paper Series) - F. Pammolli, 2011, "The Sustainability of European Health Care Systems: Beyond Income and Ageing", (with M. Riccaboni, L. Magazzini), The European Journal of Health Economics, accepted - F. Pammolli, 2011, “The productivity crisis in pharmaceutical R&D”, (with L. Magazzini, M. Riccaboni), Nature Reviews, vol. 10, 428-438 - F. Pammolli, 2011, "Innovation and Corporate Dynamics: A Theoretical Framework", (with J. Growiec, M. Riccaboni), working paper - F. Pammolli, 2010, "Scale-free models for the structure of business firm networks", (with M. Kitsak, M. Riccaboni, S. Havlin, H.E. Stanley), Physical Review E, vol. 81 - F. Pammolli, 2009, "Patent Disclosure and R&D Competition in Pharmaceuticals", (with L. Magazzini, M. Riccaboni, M.A. Rossi), Economics of Innovation and New Technology, 18(5), 467–486 - F. Pammolli, 2005, "Intellectual Property, Technological Regimes and Market Dynamics", (with M. A. Rossi), Economia e Politica Industriale, 2/2005 - F. Pammolli, 2006, "Growth and Diversification Patterns of the Worldwide Pharmaceutical Industry", (with Giulio Bottazzi and Angelo Secchi), in G. Dosi e M. Mazzucato (eds), Knowledge Accumulation and Industry Evolution. The Case of Pharma-Biotech, Cambridge University Press, Cambridge, UK, pp. 208-233 - F. Pammolli, 2005, "The Growth of Business Firms: Theoretical Framework and Empirical Evidence", (with D. Fu, S.V. Buldyrev, M. Riccaboni, K. Yamasaki, K. Matia, H.E. Stanley) Proceedings of the National Academy of Sciences, 102(52), 18801-18806 (cover article) - F. Pammolli, 2005, "Economic Evaluation of HIV Treatments: The I.CO.N.A. Cohort Study", (with M. Merito, A. Bonaccorsi, M. Riccaboni, G. Baio, C. Arici, A. D'Arminio Monforte, P. Pezzotti, D. Corsini, A. Tramarin, R. Cauda, V. Colangeli, G. Pastore), Health Policy, 74(3), 304-313 - F. Pammolli, 2005, "Medical Devices Competitiveness and Impact on Public Health Expenditure", (with M. Riccaboni, C. Oglialoro, L. Magazzini, N. Salerno, G. Baio), Entreprise Directorate-General, European Commission, Bruxelles. - F. Pammolli, 2005, "Pharmaceuticals Analysed through the Lens of a Sectoral Innovation System", (with M. McKelvey, L. Orsenigo), Part II.3 in F. Malerba (Ed.), Sectoral Systems of Innovation. Concepts, Issues and Analyses of Six Major Sectors in Europe, Cambridge University Press - F. Pammolli, 2004, "Statistical Properties of Business Firm Structure and Growth", (with K. Matia, D. Fu, S. V. Buldyrev, M. Riccaboni), Europhysics Letters, 67(3), 493-503 - F. Pammolli, 2004, "Market Structure and Drug Innovation", (with M. Riccaboni), Health Affairs, 23(1), 48-50 - F. Pammolli, 2004, "The Nature and Extent of the Market for Technology in Biopharmaceuticals" (with A. Arora, A. Gambardella, M. Riccaboni), Part 2, pp. 175-202, in F. Cesaroni, A. Gambardella e W. Garcia-Fontes (Eds.), R&D, Innovation and Competitiveness in the European Chemical Industry, Springer, Dordrecht, NL - F. Pammolli, 2004, "Dynamic Competition in Pharmaceuticals: On Patent Expiry, Generic Penetration and Industry Structure", (with L. Magazzini, M. Riccaboni), European Journal of Health Economics, 5(2), 175-182 - F. Pammolli, 2004, "Technological Competencies in Networks of Innovators", (with M. Riccaboni), Chap. 6 in J. Cantwell, A. Gambardella, O. Granstrand (Eds.) The Economics and Management of Technological Diversification. Routledge studies in the modern world economy, Routledge, London, UK - F. Pammolli, 2003, "On Size and Growth of Business Firms", (with G. De Fabritiis, M. Riccaboni) Physica A, 324(1-2), pp. 38-44 - F. Pammolli, 2003, "Technological Regimes and the Evolution of Networks. Lessons from Biotechnology and Pharmaceuticals", (with M. Riccaboni), International Journal of Technology Management, 25(3), pp. 334-349 - F. Pammolli, 2003, "Public Research and Industrial Innovation: A comparison of U.S. and European Innovation Systems in the Life Sciences", (with J. Owen-Smith, W.W. Powell, M. Riccaboni), Chap. 10 in A. Geuna, A. Salter, E. Steinmueller, (Eds.), Science and Innovation: Rethinking the Rationales for Funding and Governance, Edward Elgar, Cheltenham - F. Pammolli, 2002, "Innovation and Competitiveness in European Biotechnology", (with A. Allansdottir, A. Bonaccorsi, A. Gambardella, M. Mariani, L. Orsenigo, , M. Riccaboni), Enterprise Papers n. 7, Enterprise Directorate-General, European Commission, Bruxelles. - F. Pammolli, 2002, "Technological Regimes and the Growth of Networks: An Empirical Analysis", (with M. Riccaboni), Small Business Economics, 19(3), 205-215 - F. Pammolli, 2002, "The Intensity of Competition after Patent Expiry in Pharmaceuticals: a Cross-country Analysis", (with L. Magazzini, L.Orsenigo), Revue d'Economie Industrielle, 99, 107-132 - F. Pammolli, 2002, "A Comparison of U.S. and European University-Industry Relations in the Life Sciences", (with J. Owen-Smith, W.W. Powell, M. Riccaboni), Management Science, 48(1), 24-43. Also in M. McKelvey & L. Orsenigo (Eds.), The Economics of Biotechnology, Volume II, 342-361, Edward Edgar, Cheltenham - F. Pammolli, 2002, "On Firm Growth in Networks", (with M. Riccaboni), Research Policy, 31(8-9), 1405-1416 - F. Pammolli, 2002, "Europe and the United States: The Power of Networks. Lessons from Technology Transfer", (with J. Owen-Smith, , W.W. Powell, M. Riccaboni ), Biofutur, 222, 26-29 - F. Pammolli, 2001, "The Nature and the Extent of Markets for Technology", (with A. Arora, A. Gambardella, M. Riccaboni), CNRS, Collection Les Cahiers de l'Innovation, Cahier n. 37 - F. Pammolli, 2001, "Innovation and Corporate Growth in the Evolution of the Drug Industry", (with G. Bottazzi, G. Dosi, M. Lippi, , M. Riccaboni), International Journal of Industrial Organization, 19 (7), 1161-1187 - F. Pammolli, 2001, "Technological Change and Network Dynamics: Lessons from the Pharmaceutical Industry", (with L. Orsenigo, M. Riccaboni), Research Policy, 30(3), 485-508. Also in M. McKelvey & L. Orsenigo (Eds.), The Economics of Biotechnology, Volume II, 172-198, Edward Edgar, Cheltenham, UK - F. Pammolli, 2001, "Variety and Irreversibility in Scientific and Technological Systems: the Evolution of an Industry Network", (with L. Orsenigo, M. Riccaboni), in A. Nicita, U. Pagano (Eds.), The Evolution of Economic Diversity, Routledge, London, 216-239 - F. Pammolli, 2001, "Global Competitiveness in Pharmaceuticals: A European Perspective" (with A. Gambardella, L. Orsenigo), DG Enterprise, European Commission, 2001. - F. Pammolli, 1998, "The Evolution of Knowledge and the Dynamics of an Industry Network" (with a. Bonaccorsi, L. Orsenigo, M. Riccaboni, G. Turchetti), The Journal of Management and Governance, 1(2), 147-175
Fabio Pammolli's Recent Publications in Italian:
- F. Pammolli, 2011, "La distribuzione dei farmaci tra progetti di riforma e incertezze", (with N. C. Salerno), Economia e politica industriale, 38(2), 125-148. - F. Pammolli, 2011, "Sistemi sanitari regionali alla sfida del federalismo: una proposta per il finanziamento federalista della sanità", (with N. C. Salerno), EyesREg Giornale di Scienze Regionali, 1(1). - F. Pammolli, 2010, "Come velocizzare il passaggio al sistema di calcolo contributivo delle pensioni? Una proposta operativa per rafforzare l'aggancio alla vita attesa", (with N. C. Salerno), Rivista del diritto della sicurezza sociale 1/2010, 109-122. - F. Pammolli, 2009, "Requisiti anagrafici di accesso alle pensioni differenziati tra pilastro pubblico e pilastro privato, per riformare il welfare system rispettando le scelte individuali", (with N. C. Salerno), Rivista del diritto della sicurezza sociale 2/2009, 433-440. - F. Pammolli, 2009, "Corte di giustizia, età di pensionamento di vecchiaia per le donne e riforma delle pensioni e del welfare in Italia", (with N. C. Salerno), Rivista del diritto della sicurezza sociale 1/2009, 143-148. - F. Pammolli, 2008, "La Sanità in Italia - Federalismo, regolazione dei mercati, sostenibilità delle finanze pubbliche", (with N. C. Salerno), Il Mulino, Bologna |
Personal Information
Research Area
PhD Program
Email Addresses
|
|||||||||
| IMT is not responsible for the contents of this page, which are under the exclusive control of Fabio Pammolli. | ||||||||||
|
||||||||||